Profil
Ms. Jennifer E.
Pardi is a Managing Director, Global Head of Equity Capital Markets & Co-Head of US Securities at Canaccord Genuity LLC.
She is responsible for oversight of Canaccord Genuity’s global ECM activities, with a focus on driving coordination and best practices across all regions to drive optimal outcomes for our corporate and institutional clients.
Ms. Pardi was previously employed as an Independent Director by GreenLight Biosciences Holdings PBC.
She also served on the board at Environmental Impact Acquisition Corp.
She received her undergraduate degree from the University of Connecticut and an MBA from Suffolk University.
Aktiva positioner av Jennifer Pardi
| Företag | Position | Start |
|---|---|---|
Canaccord Genuity LLC
Canaccord Genuity LLC Investment Banks/BrokersFinance Provides brokerage services | Direktör för Forskning - Aktier | 2003-09-01 |
Tidigare kända positioner av Jennifer Pardi
| Företag | Position | Slut |
|---|---|---|
| GREENLIGHT BIOSCIENCES HOLDINGS | Direktör/Styrelseledamot | 2023-07-24 |
| GREENLIGHT BIOSCIENCES HOLDINGS PBC | Direktör/Styrelseledamot | - |
Jennifer Pardis utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Suffolk University
Suffolk University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Connecticut
University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Canaccord Genuity LLC
Canaccord Genuity LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Environmental Impact Acquisition Corp.
Environmental Impact Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
GreenLight Biosciences Holdings PBC
GreenLight Biosciences Holdings PBC BiotechnologyHealth Technology Operates as a biotechnology company that develops ribonucleic acid products | Health Technology |
















